4.4 Article

A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and CHIV-1 primary viruses

Journal

VIROLOGY
Volume 353, Issue 2, Pages 268-282

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2006.04.043

Keywords

HIV-1; vaccine; neutralization antibody; consensus inummogens

Categories

Funding

  1. NIAID NIH HHS [R21AI55386, N01 AI 85338, P0-1, AI061734, P01 AI061734, P01 AI52816, P30 AI051445, P01 AI052816, P01 AI 28147, P01 AI046023, P01 AI028147, R21 AI055386, N01 AI085338-002, P30 AI51445] Funding Source: Medline

Ask authors/readers for more resources

HIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. However, to date HIV-1 vaccine candidate immunogens have not induced potent and broadly neutralizing antibodies against subtype C primary isolates. We have used a centralized gene strategy to address HIV-1 diversity and generated a group M consensus envelope gene with shortened consensus variable loops (CON-S) for comparative studies with wild-type (WT) Env immunogens. Our results indicate that the consensus HIV-1 group M CON-S Env elicited cross-subtype neutralizing antibodies of similar or greater breadth and titer than the WT Envs tested, indicating the utility of a centralized gene strategy. Our study also shows the feasibility of iterative improvements in Env immunogenicity by rational design of centralized genes. (c) 2006 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available